Hepatic Oncology
Hepatic Oncology publishes original research studies and reviews addressing preventive, diagnostic and therapeutic approaches to all types of cancer of the liver, in both the adult and pediatric populations. The journal also highlights significant advances in basic and translatio...
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
0,37
H-index
3
Docs (year)
4
Docs 3y
6
Total refs
181
Cites 3y
7
Citable 3y
6
Cites/Doc 2y
1.17
Ref/Doc
45.25
Immediate OA
1274 €
Embargoed OA
NPD
Non OA / Submission
- €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Molecular classification of hepatocellular carcinoma: potential therapeutic implications
Mechanisms of doxorubicin resistance in hepatocellular carcinoma
Biomarker development for hepatocellular carcinoma early detection: current and future perspectives
Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress
STAT3 in hepatocellular carcinoma: new perspectives
Dysregulated fatty acid metabolism in hepatocellular carcinoma
RFA plus lyso-thermosensitive liposomal doxorubicin: in search of the optimal approach to cure intermediate-size hepatocellular carcinoma
Hepatocellular carcinoma treatment: hurdles, advances and prospects
Systemic treatments for hepatocellular carcinoma: challenges and future perspectives
The biological and clinical challenge of liver cancer heterogeneity
Malignant transformation of hepatocellular adenoma
Locoregional therapies in cholangiocarcinoma
Molecular classification of hepatocellular adenomas: impact on clinical practice
The role of the innate immune system in the development and treatment of hepatocellular carcinoma
Liver cancer oncogenomics: opportunities and dilemmas for clinical applications
Radiologic criteria of response to systemic treatments for hepatocellular carcinoma
A perspective on molecular therapy in cholangiocarcinoma: present status and future directions
The role of AEG-1 in the development of liver cancer
Targeting glucose metabolism in cancer: a new class of agents for loco-regional and systemic therapy of liver cancer and beyond?
How Rap and its GEFs control liver physiology and cancer development. C3G alterations in human hepatocarcinoma
Tivantinib in MET-high hepatocellular carcinoma patients and the ongoing Phase III clinical trial
JAK/STAT signaling in hepatocellular carcinoma
The impact of antiviral therapy on hepatocellular carcinoma epidemiology
Apoptosis in liver carcinogenesis and chemotherapy